Skip to main content
Caplight Logo









Averywell

Averywell

Private
ManchesterHealthcare & Life Scienceshttps://averywell.com/

Last Round

Pre Seed

Apr 27, 2024

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Averywell is a med-tech company that develops a non-invasive, miRNA-based liquid biopsy technology for early lung cancer detection and management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

liquid biopsylung cancer screeninglung cancer blood testnon-invasive diagnosticsAI diagnosticsmicroRNA biomarkersearly cancer detectionprecision medicineMedTechlung nodule management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Averywell Comparables

Compare Averywell with similar companies based on industry and business-model similarity.

Averywell comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oxford Cancer Analytics
83%
Hummingbird Diagnostics GmbH
81%
Biomark Diagnostics Inc.
77%

Averywell Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedApr 27, 2024

Key People

Founding team and executive leadership

Cherry NY CHIA

Founder & CEO

Founding Team

Averywell Investors

Notable investors and investment history

Averywell investors
InvestorRounds
Barclays Eagle LabsAccelerator
Genesis VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 270% MoM, from 319 to 1.2K.

  • Feb 17, 2026

    Grew 150% QoQ, from 2 to 5 employees.

Averywell Filings

Explore SEC and related filing metadata, where available.

Averywell filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Averywell's valuation, stock price, and market status.

Is Averywell a public or private company?

Averywell is a private company.

What is the current stock price of Averywell?

Averywell is a private company with no public stock price. No recent secondary market data is available.

How much is Averywell worth (valuation)?

Valuation information for Averywell is not publicly available.

Can I buy Averywell stock?

Averywell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Averywell's last funding round?

Averywell's most recent funding round was Pre Seed on April 27, 2024.

Who are the main investors in Averywell?

Key investors in Averywell include Genesis Ventures.

Will Averywell IPO soon?

No public IPO plans have been announced for Averywell.

How can I track Averywell secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Averywell's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersManchester
Employee Range3
Year Founded2023
Last FundingApr 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?